Keywords: kos/fuisz, file, once-daily, ismn, fuisz, technologies, partner
Kos/Fuisz File For Once-Daily ISMN
Article | 28 April 1998
Fuisz Technologies and partner Kos Pharmaceuticals have filed anAbbreviated New Drug Application in the USA for a once-a-day isosorbide-5-mononitrate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
